Pfizer Stops COVID Pill Trial After Latest Results Showed It Did Not Reduce Symptoms, Hospitalizations And Deaths

According to a statement by the company, Pfizer has stopped COVID pill trial after the latest results showed that it did not reduce symptoms, hospitalizations and deaths.

Pfizer has stated it will halt participation in a clinical trial for Paxlovid, its COVID-19 antiviral medication, for standard-risk COVID-19 patients after the most recent findings revealed the medication did not numerically greatly lower symptoms, hospitalizations, or fatalities.

In more than 65 nations, including t...

Subscribe to view this content.

Explore exclusive GGI coverage of Donald Trump’s assassination attempt.

 
Do you have a tip or sensitive material to share with GGI? Are you a journalist, researcher or independent blogger and want to write for us? You can reach us at [email protected].